Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant gastric function study
NCT04849559Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroparesis comparing Tradipitant with Placebo (2 arms). Primary endpoints: Fasting Gastric Volume as Measured by Single Photon Emission Computed Tomography (SPECT) at 9 days, Accommodation Volume as Measured by SPECT at 9 days and 2 more. Started Feb 2021; status: completed.
02
Drugs
tradipitant
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04849559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04849559.